Skip to content

Quick ratio at other companies

Pfizer logo
PfizerPFE
1.2×0.0×
Cardinal Health logo
Cardinal HealthCAH
0.5×0.0×
McKesson logo
McKessonMCK
0.5×0.0×
Cencora logo
CencoraCOR
0.6×+0.1×
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
1.8×-1.1×
AbbVie logo
AbbVieABBV
0.7×0.0×

Other financials

Income statement

See full
Revenue$722.5M+3.9%
Gross profit$320.1M+25.1%
Operating income$141.8M+41.3%
Net income$62.3M+411%
EPS (diluted)$0.19+375%

Balance sheet

See full
Cash & equivalents$197.7M+234%
Total debt$2.6B+17.7%
Total equity-$45.4M+65.5%
Total assets$3.5B+5.2%

Cash flow

See full
Operating cash flow-$26.7M-461%
CapEx$8.2M-37.9%
Free cash flow-$34.9M-507%

Valuation

See full
Market cap$5.17B+51.0%
Enterprise value$7.55B+33.4%
P/E42.4×
P/S1.7×+0.5×

Profitability

See full
Gross margin38.7%+2.0pp
Operating margin14.3%+1.6pp
Net margin4%+3.6pp
FCF margin7.9%-1.0pp

Returns & leverage

See full
Return on equity-52.8%-12.7pp
Debt / equity127.9×+119×
Current ratio2.5×+1.1×

Where this comes from

Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amneal Pharmaceuticals, Inc.'s quick ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amneal Pharmaceuticals, Inc.'s quick ratio?
Amneal Pharmaceuticals, Inc. (AMRX) reported quick ratio of 1.6× in Q1 2026.
How has Amneal Pharmaceuticals, Inc.'s quick ratio changed year-over-year?
Amneal Pharmaceuticals, Inc.'s quick ratio increased by 88.0% year-over-year, from 0.8× to 1.6×.
What is the long-term trend for Amneal Pharmaceuticals, Inc.'s quick ratio?
Over 5 years (2020 to 2025), Amneal Pharmaceuticals, Inc.'s quick ratio has grown at a -1.1% compound annual growth rate (CAGR), from 1.6× to 1.5×.
What does quick ratio mean?
Current assets excluding inventory, divided by current liabilities at the quarter end (the 'acid-test'). A stricter liquidity measure that excludes the least-liquid current asset.